A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung

Thorax
Arlene M A GlasgowClifford C Taggart

Abstract

Secretory leucocyte protease inhibitor and elafin are members of the whey acidic protein (WAP), or WAP four disulfide-core (WFDC), family of proteins and have multiple contributions to innate defence including inhibition of neutrophil serine proteases and inhibition of the inflammatory response to lipopolysaccharide (LPS). This study aimed to explore potential activities of WFDC12, a previously uncharacterised WFDC protein expressed in the lung. Recombinant expression and purification of WFDC12 were optimised in Escherichia coli. Antiprotease, antibacterial and immunomodulatory activities of recombinant WFDC12 were evaluated and levels of endogenous WFDC12 protein were characterised by immunostaining and ELISA. Recombinant WFDC12 inhibited cathepsin G, but not elastase or proteinase-3 activity. Monocytic cells pretreated with recombinant WFDC12 before LPS stimulation produced significantly lower levels of the pro-inflammatory cytokines interleukin-8 and monocyte chemotactic protein-1 compared with cells stimulated with LPS alone. Recombinant WFDC12 became conjugated to fibronectin in a transglutaminase-mediated reaction and retained antiprotease activity. In vivo WFDC12 expression was confirmed by immunostaining of human lung t...Continue Reading

References

Nov 1, 1996·Infection and Immunity·P S HiemstraJ H Dijkman
Feb 19, 2000·Journal of Molecular Graphics & Modelling·S RanganathanK R Nicholas
Jan 10, 2002·Biochemical and Biophysical Research Communications·Ake Lundwall, Adam Clauss
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koichi HagiwaraToshihiro Nukiwa
Apr 12, 2003·Critical Care Medicine·Theo J MoraesGregory P Downey
Jan 26, 2005·American Journal of Respiratory Cell and Molecular Biology·Jonathan W McMichaelJean-Michel Sallenave
Dec 15, 2005·The Journal of Experimental Medicine·Clifford C TaggartNoel G McElvaney
Sep 19, 2006·The Journal of Biological Chemistry·Marcus W ButlerNoel G McElvaney
Oct 20, 2006·The European Respiratory Journal·M GrieseD Hartl
Aug 5, 2008·Trends in Immunology·Colin D Bingle, Annapurna Vyakarnam
Mar 28, 2009·American Journal of Respiratory and Critical Care Medicine·Murali ShyamsundarDaniel F McAuley
Sep 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jae W LeeMichael A Matthay
Sep 16, 2009·Current Protein & Peptide Science·Frederick HarrisDavid A Phoenix
Dec 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sinéad WeldonClifford C Taggart
Apr 17, 2010·American Journal of Respiratory Cell and Molecular Biology·Jean-Michel Sallenave
Sep 28, 2010·American Journal of Respiratory and Critical Care Medicine·Thelma R CraigDaniel F McAuley
Sep 23, 2011·Biochemical Society Transactions·Lee Shaw, Oliver Wiedow
Dec 15, 2012·Biochimie·Denise T F McLeanDavid J Timson

❮ Previous
Next ❯

Citations

Jul 15, 2017·The European Respiratory Journal·Aaron ScottSinéad Weldon
Dec 9, 2016·Biological Chemistry·Donna M SmallClifford C Taggart
Oct 10, 2020·Biology of Reproduction·Alexandre D AndradeErick J R Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.